1. Home
  2. CERT vs GRAL Comparison

CERT vs GRAL Comparison

Compare CERT & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERT
  • GRAL
  • Stock Information
  • Founded
  • CERT 2008
  • GRAL 2016
  • Country
  • CERT United States
  • GRAL United States
  • Employees
  • CERT N/A
  • GRAL N/A
  • Industry
  • CERT Retail: Computer Software & Peripheral Equipment
  • GRAL
  • Sector
  • CERT Technology
  • GRAL
  • Exchange
  • CERT Nasdaq
  • GRAL NYSE
  • Market Cap
  • CERT 2.3B
  • GRAL 1.8B
  • IPO Year
  • CERT 2020
  • GRAL N/A
  • Fundamental
  • Price
  • CERT $13.17
  • GRAL $40.73
  • Analyst Decision
  • CERT Buy
  • GRAL Hold
  • Analyst Count
  • CERT 7
  • GRAL 2
  • Target Price
  • CERT $15.92
  • GRAL $16.00
  • AVG Volume (30 Days)
  • CERT 1.4M
  • GRAL 1.9M
  • Earning Date
  • CERT 02-26-2025
  • GRAL 02-20-2025
  • Dividend Yield
  • CERT N/A
  • GRAL N/A
  • EPS Growth
  • CERT N/A
  • GRAL N/A
  • EPS
  • CERT N/A
  • GRAL N/A
  • Revenue
  • CERT $372,797,000.00
  • GRAL $125,595,000.00
  • Revenue This Year
  • CERT $10.48
  • GRAL $35.17
  • Revenue Next Year
  • CERT $9.94
  • GRAL $16.85
  • P/E Ratio
  • CERT N/A
  • GRAL N/A
  • Revenue Growth
  • CERT 5.62
  • GRAL 34.90
  • 52 Week Low
  • CERT $9.41
  • GRAL $12.33
  • 52 Week High
  • CERT $19.87
  • GRAL $63.99
  • Technical
  • Relative Strength Index (RSI)
  • CERT 48.29
  • GRAL N/A
  • Support Level
  • CERT $13.54
  • GRAL N/A
  • Resistance Level
  • CERT $15.69
  • GRAL N/A
  • Average True Range (ATR)
  • CERT 0.70
  • GRAL 0.00
  • MACD
  • CERT -0.16
  • GRAL 0.00
  • Stochastic Oscillator
  • CERT 2.70
  • GRAL 0.00

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

About GRAL GRAIL INC

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.

Share on Social Networks: